Sökning: WFRF:(Denayer Sarah) >
Vaccine effectivene...
-
Rose, Angela M.C.Epiconcept, Paris
(författare)
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation : I-MOVECOVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022
- Artikel/kapitelEngelska2023
Förlag, utgivningsår, omfång ...
Nummerbeteckningar
-
LIBRIS-ID:oai:lup.lub.lu.se:685722a5-24a9-4f3e-b57e-157060601450
-
https://lup.lub.lu.se/record/685722a5-24a9-4f3e-b57e-157060601450URI
-
https://doi.org/10.2807/1560-7917.ES.2023.28.47.2300187DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:art swepub-publicationtype
-
Ämneskategori:ref swepub-contenttype
Anmärkningar
-
Introduction: The I-MOVE-COVID-19 and VEBIS hospital networks have been measuring COVID-19 vaccine effectiveness (VE) in participating European countries since early 2021. Aim: We aimed to measure VE against PCR-confirmed SARS-CoV-2 in patients ≥20 years hospitalised with severe acute respiratory infection (SARI) from December 2021 to July 2022 (Omicron-dominant period). Methods: In both networks, 46 hospitals (13 countries) follow a similar test-negative case–control protocol. We defined complete primary series vaccination (PSV) and first booster dose vaccination as last dose of either vaccine received≥14 days before symptom onset (stratifying first booster into received<150 and≥150 days after last PSV dose). We measured VE overall, by vaccine category/product, age group and time since first mRNA booster dose, adjusting by site as a fixed effect, and by swab date, age, sex, and presence/absence of at least one commonly collected chronic condition. Results: We included 2,779 cases and 2,362 controls. The VE of all vaccine products combined against hospitalisation for laboratory-confirmed SARS-CoV-2 was 43% (95% CI: 29–54) for complete PSV (with last dose received≥150 days before onset), while it was 59% (95% CI: 51–66) after addition of one booster dose. The VE was 85% (95% CI: 78–89), 70% (95% CI: 61–77) and 36% (95% CI: 17–51) for those with onset 14–59 days, 60–119 days and 120–179 days after booster vaccination, respectively. Conclusions: Our results suggest that, during the Omicron period, observed VE against SARI hospitalisation improved with first mRNA booster dose, particularly for those having symptom onset<120 days after first booster dose.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Nicolay, NathalieEuropean Centre for Disease Prevention and Control
(författare)
-
Martín, Virginia SandonisSpanish National Centre for Microbiology
(författare)
-
Mazagatos, ClaraCIBER Epidemiology and Public Health (CIBERESP),Carlos III Health Institute
(författare)
-
Petrović, GorankaCroatian National Institute of Public Health, Zagreb
(författare)
-
Baruch, JoaquinHealth Promotion and Disease Prevention Directorate
(författare)
-
Denayer, SarahSciensano
(författare)
-
Seyler, LucieUniversitair Ziekenhuis Brussel
(författare)
-
Domegan, LisaHealth Protection Surveillance Centre
(författare)
-
Launay, OdileUniversité Paris Cité,Cochin Hospital,National Institute for Health and Medical Research, France
(författare)
-
Machado, AusendaNational Institute of Health Dr. Ricardo Jorge
(författare)
-
Burgui, CristinaCIBER Epidemiology and Public Health (CIBERESP),Health Research Institute of Navarra (IDISNA)
(författare)
-
Vaikutyte, RobertaLithuanian University of Health Sciences
(författare)
-
Niessen, F. AnnabelNational Institute for Public Health and the Environment (RIVM)
(författare)
-
Loghin, Isabela I.St. Parascheva Clinical Hospital of Infectious Diseases,Grigore T. Popa University of Medicine and Pharmacy
(författare)
-
Husa, PetrUniversity Hospital Brno,Masaryk University
(författare)
-
Aouali, NasseraLuxembourg Institute of Health
(författare)
-
Panagiotakopoulos, GeorgeNational Public Health Organisation (EODY)
(författare)
-
Tolksdorf, KristinRobert Koch Institut
(författare)
-
Horváth, Judit KrisztinaSemmelweis University
(författare)
-
Howard, JenniferEpiconcept, Paris
(författare)
-
Pozo, FranciscoSpanish National Centre for Microbiology
(författare)
-
Gallardo, VirtudesDirección General de Salud Pública y Ordenación Farmacéutica
(författare)
-
Nonković, DianaTeaching Public Health Institute of Split-Dalmatia County
(författare)
-
Džiugytė, AušraHealth Promotion and Disease Prevention Directorate
(författare)
-
Bossuyt, NathalieSciensano
(författare)
-
Demuyser, ThomasUniversitair Ziekenhuis Brussel
(författare)
-
Duffy, RóisínHealth Protection Surveillance Centre
(författare)
-
Nguyen, Liem Binh LuongCochin Hospital
(författare)
-
Kislaya, IrinaNational Institute of Health Dr. Ricardo Jorge
(författare)
-
Martínez-Baz, IvánHealth Research Institute of Navarra (IDISNA),CIBER Epidemiology and Public Health (CIBERESP)
(författare)
-
Gefenaite, GiedreLund University,Lunds universitet,Aktivt och hälsosamt åldrande,Forskargrupper vid Lunds universitet,LU profilområde: Proaktivt åldrande,Lunds universitets profilområden,Active and Healthy Ageing Research Group,Lund University Research Groups,LU Profile Area: Proactive Ageing,Lund University Profile areas,Lithuanian University of Health Sciences(Swepub:lu)gi4300ge
(författare)
-
Knol, Mirjam J.National Institute for Public Health and the Environment (RIVM)
(författare)
-
Popescu, CorneliuVictor Babes National Institute,Carol Davila University of Medicine and Pharmacy
(författare)
-
Součková, LenkaUniversity Hospital Brno
(författare)
-
Simon, MarcCentre Hospitalier de Luxembourg
(författare)
-
Michelaki, StellaNational Public Health Organisation (EODY)
(författare)
-
Reiche, JanineRobert Koch Institut
(författare)
-
Ferenczi, AnnamáriaSemmelweis University
(författare)
-
Delgado-Sanz, ConcepciónCarlos III Health Institute,CIBER Epidemiology and Public Health (CIBERESP)
(författare)
-
Makarić, Zvjezdana LovrićCroatian National Institute of Public Health, Zagreb
(författare)
-
Cauchi, John PaulHealth Promotion and Disease Prevention Directorate
(författare)
-
Barbezange, CyrilSciensano
(författare)
-
Van Nedervelde, ElsUniversitair Ziekenhuis Brussel
(författare)
-
O’Donnell, JoanHealth Protection Surveillance Centre
(författare)
-
Durier, ChristineNational Institute for Health and Medical Research, France
(författare)
-
Guiomar, RaquelNational Institute of Health Dr. Ricardo Jorge
(författare)
-
Castilla, JesúsCIBER Epidemiology and Public Health (CIBERESP),Health Research Institute of Navarra (IDISNA)
(författare)
-
Jonikaite, IndrėLithuanian University of Health Sciences
(författare)
-
Bruijning-Verhagen, Patricia C.J.L.University Medical Center Utrecht,National Institute for Public Health and the Environment (RIVM)
(författare)
-
Epiconcept, ParisEuropean Centre for Disease Prevention and Control
(creator_code:org_t)
-
I-MOVE-COVID-19 hospital study team
-
VEBIS hospital study team
Sammanhörande titlar
-
Ingår i:Eurosurveillance28:471025-496X
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Rose, Angela M.C ...
-
Nicolay, Nathali ...
-
Martín, Virginia ...
-
Mazagatos, Clara
-
Petrović, Gorank ...
-
Baruch, Joaquin
-
visa fler...
-
Denayer, Sarah
-
Seyler, Lucie
-
Domegan, Lisa
-
Launay, Odile
-
Machado, Ausenda
-
Burgui, Cristina
-
Vaikutyte, Rober ...
-
Niessen, F. Anna ...
-
Loghin, Isabela ...
-
Husa, Petr
-
Aouali, Nassera
-
Panagiotakopoulo ...
-
Tolksdorf, Krist ...
-
Horváth, Judit K ...
-
Howard, Jennifer
-
Pozo, Francisco
-
Gallardo, Virtud ...
-
Nonković, Diana
-
Džiugytė, Aušra
-
Bossuyt, Nathali ...
-
Demuyser, Thomas
-
Duffy, Róisín
-
Nguyen, Liem Bin ...
-
Kislaya, Irina
-
Martínez-Baz, Iv ...
-
Gefenaite, Giedr ...
-
Knol, Mirjam J.
-
Popescu, Corneli ...
-
Součková, Lenka
-
Simon, Marc
-
Michelaki, Stell ...
-
Reiche, Janine
-
Ferenczi, Annamá ...
-
Delgado-Sanz, Co ...
-
Makarić, Zvjezda ...
-
Cauchi, John Pau ...
-
Barbezange, Cyri ...
-
Van Nedervelde, ...
-
O’Donnell, Joan
-
Durier, Christin ...
-
Guiomar, Raquel
-
Castilla, Jesús
-
Jonikaite, Indrė
-
Bruijning-Verhag ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Infektionsmedici ...
- Artiklar i publikationen
-
Eurosurveillance
- Av lärosätet
-
Lunds universitet